Kathryn J. Collier, Director: Regulus Therapeutics RGLS Buy · Filed 24/07/29

Trade details

Type: Insider buy
Amount: $7,280
Shares · price: 4,000 sh · $1.82 a share
Held after: 6,740 sh
Stock: Regulus Therapeutics RGLS
Person: Kathryn J. CollierDirector
Trade date: 24/07/25
Filed: 24/07/29
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +146.0%

Regulus Therapeutics trades, last 26 weeks

What else happened in Regulus Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/25~24/08/24

Kathryn J. Collier's recent trades

No other trades yet.